Is GVS TM, Inc FDA approved?

GVS TM, Inc holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are GVS TM, Inc's drugs manufactured?

The FDA register lists Covina, CA. Registered operations: labelling, finished drug manufacture.

What drugs does GVS TM, Inc make?

10 products are listed under GVS TM, Inc in the openFDA NDC Directory, most often as solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

GVS TM, Inc

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 10
Live patents: 0
Countries: 1
Base: United States

Authorisation

Registered operations

Labelling1Finished drug manufacture1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
GVS TM, Inc	1630 W Industrial Park Street, Covina, California (CA) 91722, United States (USA)	Labelling, Finished drug manufacture	2013342119067149

Catalogue

Drug listings by form and route

10 active NDC listings: 10 human prescription drug. By marketing category: NDA 10.

Dosage form	NDCs
solution	10

Route	NDCs
intravenous	10

Labeller name on the listing	NDCs
gvs tm inc	10

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
AS-3	AS-3	solution, intravenous	87069-460NDA
AS-3	AS-3	solution, intravenous	87069-462NDA
Blood Collection System	CP2D/AS-3 triple with sampling system	solution, intravenous	87069-121NDA
CP2D	CP2D	solution, intravenous	87069-455NDA
Leukotrap RC PL System	CP2D/AS-3 Anticoagulant and Additive System	solution, intravenous	87069-123NDA
Leukotrap RC System	CP2D/AS-3 Anticoagulant and Additive System	solution, intravenous	87069-129NDA
Leukotrap WB System	CPDA-1 Blood Bag Collection System	solution, intravenous	87069-136NDA
Leukotrap WB System	CPDA-1 Blood Bag Collection System	solution, intravenous	87069-736NDA
Leukotrap WB System - CP2D	CP2D/AS-3 - Anticoagulant and Additive System	solution, intravenous	87069-126NDA
Leukotrap WB system - CP2D	CP2D/AS-3 Anticoagulant and Additive System	solution, intravenous	87069-726NDA

Compare

Comparable companies in United States

Hahnemann Laboratories, Inc. dba Alpine Pharmaceuticals1 site · 4,853 NDC
NuCare Pharmaceuticals,Inc.1 site · 1,393 NDC
Greer Laboratories, Inc.1 site · 1,328 NDC
ASCLEMED USA INC. DBA ENOVACHEM1 site · 789 NDC
Golden State Medical Supply Inc.1 site · 670 NDC
Rising Pharma Holdings, Inc.1 site · 532 NDC
HF Acquisition Co LLC1 site · 363 NDC
ANI Pharmaceuticals, Inc.1 site · 299 NDC
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 site · 273 NDC
Newton Laboratories, Inc.1 site · 271 NDC

Enquiry

Common questions

Is GVS TM, Inc FDA approved?: GVS TM, Inc holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are GVS TM, Inc's drugs manufactured?: The FDA register lists Covina, CA. Registered operations: labelling, finished drug manufacture.
What drugs does GVS TM, Inc make?: 10 products are listed under GVS TM, Inc in the openFDA NDC Directory, most often as solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.